Logo image of CMBT

CMB TECH NV (CMBT) Stock Fundamental Analysis

USA - NYSE:CMBT - BE0003816338 - Common Stock

9.2 USD
-0.31 (-3.26%)
Last: 9/19/2025, 8:04:00 PM
9.22 USD
+0.02 (+0.22%)
After Hours: 9/19/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, CMBT scores 4 out of 10 in our fundamental rating. CMBT was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. There are concerns on the financial health of CMBT while its profitability can be described as average. CMBT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CMBT was profitable.
In the past year CMBT had a positive cash flow from operations.
CMBT had positive earnings in 4 of the past 5 years.
CMBT had a positive operating cash flow in 4 of the past 5 years.
CMBT Yearly Net Income VS EBIT VS OCF VS FCFCMBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

CMBT's Return On Assets of 4.58% is in line compared to the rest of the industry. CMBT outperforms 60.00% of its industry peers.
CMBT has a better Return On Equity (29.01%) than 91.43% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.07%, CMBT is doing worse than 62.38% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CMBT is significantly below the industry average of 21.66%.
The last Return On Invested Capital (4.07%) for CMBT is well below the 3 year average (9.43%), which needs to be investigated, but indicates that CMBT had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.58%
ROE 29.01%
ROIC 4.07%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
CMBT Yearly ROA, ROE, ROICCMBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

CMBT has a Profit Margin of 25.21%. This is amongst the best in the industry. CMBT outperforms 81.43% of its industry peers.
In the last couple of years the Profit Margin of CMBT has grown nicely.
CMBT has a Operating Margin of 25.71%. This is in the better half of the industry: CMBT outperforms 61.90% of its industry peers.
In the last couple of years the Operating Margin of CMBT has grown nicely.
The Gross Margin of CMBT (54.54%) is better than 63.33% of its industry peers.
In the last couple of years the Gross Margin of CMBT has remained more or less at the same level.
Industry RankSector Rank
OM 25.71%
PM (TTM) 25.21%
GM 54.54%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBT Yearly Profit, Operating, Gross MarginsCMBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CMBT is still creating some value.
Compared to 1 year ago, CMBT has less shares outstanding
Compared to 5 years ago, CMBT has less shares outstanding
Compared to 1 year ago, CMBT has a worse debt to assets ratio.
CMBT Yearly Shares OutstandingCMBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT Yearly Total Debt VS Total AssetsCMBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.72, we must say that CMBT is in the distress zone and has some risk of bankruptcy.
CMBT's Altman-Z score of 0.72 is in line compared to the rest of the industry. CMBT outperforms 40.95% of its industry peers.
A Debt/Equity ratio of 3.82 is on the high side and indicates that CMBT has dependencies on debt financing.
CMBT has a worse Debt to Equity ratio (3.82) than 87.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.82
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACC0.55
WACC7.41%
CMBT Yearly LT Debt VS Equity VS FCFCMBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

CMBT has a Current Ratio of 0.82. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CMBT (0.82) is worse than 65.71% of its industry peers.
A Quick Ratio of 0.75 indicates that CMBT may have some problems paying its short term obligations.
CMBT has a worse Quick ratio (0.75) than 63.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.75
CMBT Yearly Current Assets VS Current LiabilitesCMBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

CMBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -99.67%.
The Earnings Per Share has been growing by 43.41% on average over the past years. This is a very strong growth
CMBT shows a decrease in Revenue. In the last year, the revenue decreased by -1.96%.
Measured over the past years, CMBT shows a small growth in Revenue. The Revenue has been growing by 0.55% on average per year.
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
Revenue 1Y (TTM)-1.96%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%53.89%

3.2 Future

CMBT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -39.46% yearly.
CMBT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.58% yearly.
EPS Next Y-68.44%
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%
EPS Next 5YN/A
Revenue Next Year45.47%
Revenue Next 2Y36.6%
Revenue Next 3Y31.58%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBT Yearly Revenue VS EstimatesCMBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CMBT Yearly EPS VS EstimatesCMBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 460.00, the valuation of CMBT can be described as expensive.
Based on the Price/Earnings ratio, CMBT is valued a bit more expensive than 68.57% of the companies in the same industry.
CMBT is valuated expensively when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
CMBT is valuated cheaply with a Price/Forward Earnings ratio of 4.84.
Based on the Price/Forward Earnings ratio, CMBT is valued cheaply inside the industry as 92.86% of the companies are valued more expensively.
CMBT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.86.
Industry RankSector Rank
PE 460
Fwd PE 4.84
CMBT Price Earnings VS Forward Price EarningsCMBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CMBT is valued a bit more expensive than 61.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.24
CMBT Per share dataCMBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

CMBT has a very decent profitability rating, which may justify a higher PE ratio.
CMBT's earnings are expected to decrease with -39.46% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)10.6
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.52%, CMBT is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.18, CMBT is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.38, CMBT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.52%

5.2 History

On average, the dividend of CMBT grows each year by 116.35%, which is quite nice.
CMBT has been paying a dividend for over 5 years, so it has already some track record.
CMBT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)116.35%
Div Incr Years2
Div Non Decr Years3
CMBT Yearly Dividends per shareCMBT Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

59.41% of the earnings are spent on dividend by CMBT. This is a bit on the high side, but may be sustainable.
The Dividend Rate of CMBT has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP59.41%
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%
CMBT Yearly Income VS Free CF VS DividendCMBT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
CMBT Dividend Payout.CMBT Dividend Payout, showing the Payout Ratio.CMBT Dividend Payout.PayoutRetained Earnings

CMB TECH NV

NYSE:CMBT (9/19/2025, 8:04:00 PM)

After market: 9.22 +0.02 (+0.22%)

9.2

-0.31 (-3.26%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-13 2025-11-13/bmo
Inst Owners1.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.91B
Analysts82
Price Target11.24 (22.17%)
Short Float %4.5%
Short Ratio2.56
Dividend
Industry RankSector Rank
Dividend Yield 0.52%
Yearly Dividend5.68
Dividend Growth(5Y)116.35%
DP59.41%
Div Incr Years2
Div Non Decr Years3
Ex-Date10-01 2025-10-01 (0.05)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-173.53%
Min EPS beat(2)-198.04%
Max EPS beat(2)-149.02%
EPS beat(4)0
Avg EPS beat(4)-100.08%
Min EPS beat(4)-198.04%
Max EPS beat(4)-3.67%
EPS beat(8)4
Avg EPS beat(8)61.43%
EPS beat(12)7
Avg EPS beat(12)47.26%
EPS beat(16)10
Avg EPS beat(16)41.59%
Revenue beat(2)1
Avg Revenue beat(2)18.49%
Min Revenue beat(2)-9.81%
Max Revenue beat(2)46.8%
Revenue beat(4)3
Avg Revenue beat(4)13.62%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)46.8%
Revenue beat(8)6
Avg Revenue beat(8)20.12%
Revenue beat(12)10
Avg Revenue beat(12)34.18%
Revenue beat(16)14
Avg Revenue beat(16)38.38%
PT rev (1m)-8.24%
PT rev (3m)-10.63%
EPS NQ rev (1m)-97.37%
EPS NQ rev (3m)-97.22%
EPS NY rev (1m)2.05%
EPS NY rev (3m)2.05%
Revenue NQ rev (1m)22.04%
Revenue NQ rev (3m)45.64%
Revenue NY rev (1m)10.92%
Revenue NY rev (3m)35.76%
Valuation
Industry RankSector Rank
PE 460
Fwd PE 4.84
P/S 1.9
P/FCF N/A
P/OCF 10.78
P/B 2.19
P/tB 2.55
EV/EBITDA 13.24
EPS(TTM)0.02
EY0.22%
EPS(NY)1.9
Fwd EY20.65%
FCF(TTM)-3.02
FCFYN/A
OCF(TTM)0.85
OCFY9.28%
SpS4.83
BVpS4.2
TBVpS3.6
PEG (NY)N/A
PEG (5Y)10.6
Profitability
Industry RankSector Rank
ROA 4.58%
ROE 29.01%
ROCE 5.15%
ROIC 4.07%
ROICexc 4.16%
ROICexgc 4.26%
OM 25.71%
PM (TTM) 25.21%
GM 54.54%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
ROICexc(3y)10.41%
ROICexc(5y)N/A
ROICexgc(3y)10.46%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score2
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 3.82
Debt/FCF N/A
Debt/EBITDA 7.9
Cap/Depr 492%
Cap/Sales 80.04%
Interest Coverage 1.85
Cash Conversion 42.05%
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.75
Altman-Z 0.72
F-Score2
WACC7.41%
ROIC/WACC0.55
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
EPS Next Y-68.44%
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.96%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%53.89%
Revenue Next Year45.47%
Revenue Next 2Y36.6%
Revenue Next 3Y31.58%
Revenue Next 5YN/A
EBIT growth 1Y-41.59%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year67.95%
EBIT Next 3Y22.95%
EBIT Next 5YN/A
FCF growth 1Y-427.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-54.74%
OCF growth 3YN/A
OCF growth 5Y11.04%